Researcher

Title

• Full Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Montreal, 2009.

• Master's in Public Health, Epidemiology option, Université Paris XI, 1997.
• MD, Université Paris VI, 1994.

Over the past 20 years I have developed a research program focused on the prediction and prevention of various fetal and maternal complications including preeclampsia and fetal growth restriction, fetal aneuploidies, and preterm birth. A common aspect of the approach I am investigating is the development and validation of prenatal screening tests combining markers of different nature (clinical, biophysical and biochemical). I am also involved in the evaluation of fetal therapies, particularly fetoscopic placental laser treatment for twin-to-twin transfusion syndrome.

• Prenatal screening and diagnostics
• Preeclampsia
• Fetal therapy
• Twin pregnancies
• Congenital anomalies

Career Summary

Dr François Audibert obtained his medical degree from the University of Paris VI in 1994, with a diploma in Obstetrics and Gynecology. After a research fellowship in the division of maternal-fetal medicine, University of Memphis, Tennessee in 1995 with Dr. Sibai, he worked as teaching assistant and practitioner in maternal-fetal medicine at the Antoine Béclère hospital, University of Paris XI. He completed a Master's degree in epidemiology and clinical research (University of Paris) in 2001, and was recruited at the University of Montreal and CHU Ste-Justine in 2003. His main research studies prenatal screening, preeclampsia, and twin pregnancies. He is currently Full Professor and Head of the division of maternal-fetal medicine at the University of Montreal. He is author or co-author of more than 250 scientific publications.

Awards and Distinctions

• 2015 : Prix pour Services Distingués, SOGC 2005         
• 2013 : Short Oral Presentation Award – ISUOG 23rd World Congress on Ultrasound in Obstetrics and Gynecology, Sydney, Australia.
• 2010 : Best Oral Presentation - SOGC Annual Clinical meeting, Montreal
• 2007 : Best free communication presentation in its category. – World Congress on Ultrasound in Obstetrics and Gynecology. Florence, Italie
• 2005 : Prix Jacques Van Campenhout (Professeur de l’Année en Gynécologie-Obstétrique), Université de Montréal, 2004-2005
• 2004-2005 : CREOG Faculty Award for Excellence in Resident Education (American College of Obstetrics and Gynecology).

Presentations

• Audibert F. Le col court : cerclage, progestérone, comment s’y retrouver? FMC SOGC 30 septembre 2021
• Audibert F. L’Échographie génétique en 2022. Journée annuelle du département d’Obstétrique Gynécologie, Université Laval, Québec
• Audibert F. Fetal therapy workshop. International Society of Prenatal Diagnosis. Montreal, June 2022
• Audibert F. Que reste-t-il des signes mineurs en échographie? Conférence académique du CHU Ste-Justine. Octobre 2022
• Audibert F. Que reste-t-il des signes mineurs en échographie? Congrès annuel de l’AOGQ, Mont-Tremblant mai 2023.

Publications

• Moise KJ Jr..., Audibert F, et al; UNITY Study Group. Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn. N Engl J Med 2024.
• Chaillet N, ..., Audibert F, et al; PRISMA Trial research group. Perinatal morbidity among women with a previous caesarean delivery (PRISMA trial): a cluster-randomised trial. Lancet 2024
• Bujold E, Audibert F et al. Prospective Validation of First-Trimester Screening for Preterm Preeclampsia in Nulliparous Women (PREDICTION Study). Hypertension 2024.
• Soukkhaphone B, .., Rousseau F, Audibert F, Langlois S, Reinharz D. Expansion of non-invasive prenatal screening to the screening of 10 types of chromosomal anomalies: a cost-effectiveness analysis. BMJ Open 2023
• Carmant LS, Audibert F, Wavrant S, et al. Impact of Selective Fetal Growth Restriction on Laser Therapy Outcomes in Twin Twin Transfusion Syndrome. Fetal Diagn Ther. 2023
• Khayargoli P, Niyibizi J, Mayrand MH, Audibert F, et al; HERITAGE Study Group. Human Papillomavirus Transmission and Persistence in Pregnant Women and Neonates. JAMA Pediatr 2023
• von Dadelszen P, Audibert F et al. Halting the Canadian STRIDER randomised controlled trial of sildenafil for severe, early-onset fetal growth restriction: ethical, methodological, and pragmatic considerations. BMC Res Notes 2022
• Niyibizi J, Mayrand MH, Audibert F, …, Trottier H; HERITAGE Study Group. Association Between Human Papillomavirus Infection Among Pregnant Women and Preterm Birth. JAMA Netw Open 2021
• Rabi DM, … Audibert F…, Daskalopoulou SS. Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Can J Cardiol 2020
• Chaillet N, Dumont A, Abrahamowicz M, Pasquier JC, Audibert F, et al; QUARISMA Trial Research Group. A cluster-randomized trial to reduce cesarean delivery rates in Quebec. N Engl J Med 2015.